Synthesis and Biological Evaluation of Thiazole-Based Derivatives with Potential against Breast Cancer and Antimicrobial Agents

Int J Mol Sci. 2022 Aug 30;23(17):9844. doi: 10.3390/ijms23179844.

Abstract

Investigating novel, biologically-active coordination compounds that may be useful in the design of breast anticancer, antifungal, and antimicrobial agents is still the main challenge for chemists. In order to get closer to solving this problem, three new copper coordination compounds containing thiazole-based derivatives were synthesized. The structures of the synthesized compounds and their physicochemical characterization were evaluated based on elemental analysis, 1H and l3C nuclear magnetic resonance (NMR), flame atomic absorption spectroscopy (F-AAS), single-crystal X-ray diffraction, thermogravimetric analysis (TGA), and Fourier-transform infrared spectroscopy (FTIR). The pharmacokinetics were studied using SwissADME. The results obtained from the computational studies supported the results obtained from the MTT analysis, and the antimicrobial activity was expressed as the minimum inhibitory concentration (MIC).

Keywords: MCF7; copper complexes; drug design; thiazole derivative.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents* / chemistry
  • Antifungal Agents / pharmacology
  • Antineoplastic Agents* / pharmacology
  • Breast Neoplasms* / drug therapy
  • Female
  • Humans
  • Microbial Sensitivity Tests
  • Spectroscopy, Fourier Transform Infrared
  • Thiazoles / chemistry

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Antifungal Agents
  • Antineoplastic Agents
  • Thiazoles

Grants and funding

This research received no external funding.